(INNS)
TRASTUZUMAB KORIXETAN(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)], HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED TO CORIXETAN, COMPRISING A LINKER AND AN OCTADENTATE CHELATOR; GAMMA1 HEAVY CHAIN HUMANIZED (1-449) [VH (HOMO SAPIENS IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDRIMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 E12 (359), M14 (361) (344-448), CHS K2>DEL (449)) (121-449)], (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED...; PROPOSED INN: LIST 126(WHO)
TRASTUZUMABUM CORIXETANUM(INN)